Test category
Cytogenetics
Available Tests
Immunohistochemistry CD57 Test
The Immunohistochemistry CD57 Test helps identify CD57 positive cells in tumor tissue, aiding in cancer diagnosis and treatment planning.
Breast Monitor Panel Test
The Breast Monitor Panel Test measures CA 15.3 and CEA biomarkers in the blood to aid in breast cancer risk assessment and monitoring. Recommended for women with symptoms or family history.
Immunohistochemistry Comprehensive Panel Test
A comprehensive immunohistochemistry panel test used in oncology to identify specific proteins in cancer cells, aiding in diagnosis, tumor typing, and treatment guidance.
Breast Metastatic Marker Test
The Breast Metastatic Marker Test helps detect the spread of breast cancer to other parts of the body, aiding oncologists in treatment planning and monitoring.
Immunohistochemistry Digital Breast Cancer Panel 3 Test
An advanced diagnostic test using immunohistochemistry to analyze breast tumor tissue for key biomarkers (ER, PR, HER-2) that guide personalized cancer treatment decisions.
Bromide Total Test
Measures bromide levels in the serum to monitor therapeutic drug levels, ensuring safe and effective treatment. Confirm price before booking.
Immunohistochemistry Digital Breast Cancer Panel 4 Test
A specialized test using immunohistochemistry to analyze breast tumor tissue for key biomarkers (ER, PR, HER-2/neu, Ki67) to guide treatment decisions.
Immunohistochemistry FLI1 Test
The Immunohistochemistry FLI1 Test helps detect specific cancer types by measuring FLI1 protein expression in tumor tissues, aiding oncologists in diagnosis and treatment planning.
Immunohistochemistry MUC4 Test
The Immunohistochemistry MUC4 Test detects MUC4 protein in tumor tissue, aiding in cancer diagnosis, treatment planning, and monitoring.
Immunohistochemistry MOC31 Test
The Immunohistochemistry MOC31 Test helps identify specific markers in tumor tissues, aiding in cancer diagnosis and classification to guide treatment decisions.
Cyclsporine A Test
Monitor cyclsporine A levels in your blood. Essential for organ transplant patients and those on immunosuppressive therapy to ensure optimal drug levels and prevent rejection.
Immunohistochemistry Olig2 Test
The Immunohistochemistry Olig2 Test detects Olig2 protein in tumor tissues, aiding in the diagnosis and management of certain cancers, particularly brain and spinal cord tumors.
Kappa Lambda Light Chains Free Serum Test
Measures free kappa and lambda light chains in serum to help detect certain blood disorders, including multiple myeloma. Confirm with the laboratory before booking.
Immunohistochemistry MUC5AC Test
The Immunohistochemistry MUC5AC Test detects the MUC5AC protein in tissue samples, aiding in cancer diagnosis and characterization, particularly for lung and gastrointestinal cancers.
Kappa Lambda Light Chains Free Urine Test
Measures Kappa and Lambda light chains in urine to help detect and monitor certain cancers, particularly plasma cell disorders.
Immunohistochemistry SATB2 Test
The Immunohistochemistry SATB2 Test helps identify specific cancer types by detecting SATB2 protein expression in tumor tissues, aiding oncologists in diagnosis and treatment planning.
Her2 Neu Ca Breast
The Her2 Neu Ca Breast test helps determine if breast cancer cells overexpress the HER2 protein, guiding treatment decisions. Essential for personalized breast cancer care.
Immunohistochemistry Breast Cancer Panel 2 Test
The Immunohistochemistry Breast Cancer Panel 2 Test helps diagnose and characterize breast cancer by measuring hormone receptors and other markers on tissue samples, guiding targeted treatment.
Immunohistochemistry BRAF V600E Test
The Immunohistochemistry BRAF V600E Test helps identify a specific genetic mutation in tumor tissue, guiding cancer treatment decisions, particularly for melanoma. Confirm with the laboratory before booking.
Immunohistochemistry Cathepsin D Test
The Immunohistochemistry Cathepsin D Test detects Cathepsin D protein in tumor tissue, aiding oncologists in assessing cancer progression and guiding treatment decisions.
Immunohistochemistry Carbonic Anhydrase9 CA9 Test
The Immunohistochemistry Carbonic Anhydrase9 (CA9) Test helps in cancer diagnosis by measuring CA9 protein levels in tumor tissue. It aids oncologists in understanding tumor behavior and guiding treatment decisions.
Catecholamines Plasma Test
Measures epinephrine and norepinephrine levels in plasma to help detect hormonal imbalances related to conditions like hypertension and anxiety. Confirm with the laboratory before booking.
Cytology Cell Block Examination Test
The Cytology Cell Block Examination Test is a diagnostic procedure used to detect cancerous cells in tissues and fluids, aiding in cancer diagnosis and management.
Immunohistochemistry H3K27M H3K27me3 Test
The Immunohistochemistry H3K27M H3K27me3 Test helps identify specific markers in tumor tissues, aiding in cancer diagnosis and treatment planning.
Epstein-Barr Virus Early RNA EBERISH In Situ Hybridization Test
Detects Epstein-Barr Virus (EBV) RNA in tumor tissue to aid in the early diagnosis of EBV-related cancers like lymphomas and nasopharyngeal carcinoma.
CA 125 Ovarian Cancer Marker Test
The CA 125 Ovarian Cancer Marker Test measures a protein level in the blood, often elevated in ovarian cancer. It is used for monitoring women at risk and assessing treatment response. Confirm with the laboratory before booking.
Immunohistochemistry HBME1 Test
The Immunohistochemistry HBME1 Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.
Oncopro Lung Basic Panel Test
The Oncopro Lung Basic Panel Test helps diagnose and characterize lung tumors, aiding oncologists in treatment decisions. It analyzes key genetic markers like ALK1, ROS1, and EGFR.
CA 153 Breast Cancer Marker Test
The CA 153 Breast Cancer Marker Test measures a protein level in the blood to help monitor breast cancer progression and response to treatment. Confirm with the laboratory before booking.
Cytology Consultation Second Opinion Test
Seeking a second opinion on a cytology report? This test provides expert review of your cytopathology slides for diagnostic clarity, particularly for cancer patients. Confirm price before booking.
Immunohistochemistry LIN28 Test
The Immunohistochemistry LIN28 Test detects the LIN28 protein in tumor tissue, aiding in cancer diagnosis and treatment planning.
CA 2729 CA 153 Breast Cancer Markers Panel Test
The CA 2729 CA 153 Breast Cancer Markers Panel Test measures levels of specific antigens in the blood to aid in the diagnosis and monitoring of breast cancer. Confirm with the laboratory before booking.
Cytology Examination Body Fluids Test
Analysis of body fluids like ascitic, pleural, or pericardial fluid to help detect cancer and other diseases. Essential for early diagnosis and monitoring.
Immunohistochemistry HSP70 Test
The Immunohistochemistry HSP70 Test assesses HSP70 protein expression in tumor tissue, aiding oncologists in understanding cancer behavior, treatment planning, and prognosis.
CA Cyfra 211 Lung Cancer Marker Test
The CA Cyfra 21-1 Lung Cancer Marker Test measures a specific protein fragment in the blood that can be elevated in lung cancer. It aids in diagnosis and monitoring.
CA 199 Pancreatic Cancer Marker Test
The CA 199 Pancreatic Cancer Marker Test measures levels of the CA 19-9 antigen in the blood to help detect and monitor pancreatic cancer. Confirm with the laboratory before booking.
Immunohistochemistry Myeloperoxidase MPO Test
The Immunohistochemistry Myeloperoxidase (MPO) Test helps identify specific types of cancer, particularly myeloid malignancies, by detecting the MPO enzyme in tissue samples. This aids in diagnosis and treatment planning.
CA 2729 Breast Cancer Marker Test
The CA 2729 Breast Cancer Marker Test helps detect and monitor breast cancer. It measures specific tumor markers in the blood, aiding in early identification and treatment monitoring.
Immunohistochemistry 34Beta E12 HMWCK Test
The Immunohistochemistry 34Beta E12 HMWCK Test helps identify specific proteins in tissue samples to aid in cancer diagnosis and treatment planning.
CA 724 Gastric Cancer Marker Test
The CA 724 Gastric Cancer Marker Test helps detect and monitor gastric cancer by measuring CA 724 antigen levels in the blood. Useful for individuals with symptoms or risk factors.
Immunohistochemistry PDL1 22C3 Test
The Immunohistochemistry PDL1 22C3 Test assesses PDL1 protein expression in tumor tissue, helping oncologists determine suitability for immunotherapy.
Immunohistochemistry ALKD5F3 Test
The Immunohistochemistry ALKD5F3 Test helps identify specific cancer markers in tumor tissue, aiding in diagnosis and treatment planning.
Breast Cancer ER PR HER2 Ki67
The Breast Cancer ER PR HER2 Ki67 test analyzes key markers in breast tumor tissue to guide personalized treatment decisions. It measures hormone receptors (ER, PR), HER2 protein, and the Ki-67 proliferation marker.
Immunohistochemistry AMACR Test
The Immunohistochemistry AMACR Test helps diagnose specific cancers, particularly prostate cancer, by detecting the Alpha-methylacyl-CoA racemase (AMACR) protein in tissue samples. This aids in accurate cancer classification and treatment planning.
Lamotrigine Test
The Lamotrigine Test measures the amount of lamotrigine medication in your blood. This helps your doctor ensure you are receiving the correct dose for managing epilepsy or bipolar disorder.
Immunohistochemistry BCL6 Test
The Immunohistochemistry BCL6 Test helps diagnose and manage certain cancers by detecting the BCL6 protein in tumor tissue. This test provides valuable information for treatment decisions.
Calcitonin Test
The Calcitonin Test measures calcitonin hormone levels in the blood, primarily used for assessing certain types of thyroid cancer, like medullary thyroid carcinoma. It can aid in early detection and monitoring.
Immunohistochemistry Calcitonin Test
The Immunohistochemistry Calcitonin Test detects calcitonin in tumor tissue, aiding in the diagnosis of certain cancers like medullary thyroid carcinoma.
Calcitonin Stimulation by Calcium Pentagastrin Test
A diagnostic test measuring calcitonin levels after stimulation to help detect Medullary Thyroid Carcinoma (MTC). Essential for assessing patients at risk.
Immunohistochemistry BerEp4 EPCAM Test
The Immunohistochemistry BerEp4 EPCAM Test helps identify the EPCAM protein in tumor tissues, aiding in cancer diagnosis and treatment planning.
Iamp 21
The Iamp 21 test is a genetic test using FISH technology to detect abnormalities in the 21st chromosome, aiding in cancer diagnosis and management.
Immunohistochemistry Caldesmon Test
The Immunohistochemistry Caldesmon Test helps identify and characterize tumors, particularly smooth muscle tumors, by detecting the caldesmon protein in tissue samples.
IgH MM
The IgH MM test helps diagnose multiple myeloma and related blood disorders by detecting specific genetic changes in blood cells. Confirm with the laboratory before booking.
Immunohistochemistry CD10 Test
The Immunohistochemistry CD10 Test helps identify CD10 expression in tumor tissue, aiding in cancer classification and treatment decisions. This test is used by oncologists and pathologists.
FISH Equivocal HER2 ERBB2 Test
The FISH Equivocal HER2 ERBB2 Test helps determine HER2 gene amplification in breast cancer tissue, guiding personalized treatment decisions.
Immunohistochemistry CD117 Test
The Immunohistochemistry CD117 Test helps identify specific cancer markers, aiding in diagnosis and treatment planning for certain malignancies like GISTs.
IHC Any Single Marker HER2NEU C4D EBER Ki67
An immunohistochemistry (IHC) test to assess specific genetic markers (HER2, C4D, EBER, Ki67) in cancer tissue, guiding treatment decisions for oncology patients.
Immunohistochemistry CD138 Test
The Immunohistochemistry CD138 Test helps identify CD138 protein in tissue samples, aiding in the diagnosis and management of plasma cell disorders like multiple myeloma.
Immunohistochemistry CD15 Test
The Immunohistochemistry CD15 Test helps diagnose certain cancers by detecting the CD15 antigen in tumor tissue samples. This test aids pathologists and oncologists in accurate diagnosis and treatment planning.
Ovarian Cancer Panel Test
The Ovarian Cancer Panel Test measures CA 125 and Inhibin B levels to aid in the detection of ovarian cancer. Recommended for women with risk factors or symptoms.
Immunohistochemistry CD1a Test
The Immunohistochemistry CD1a Test helps identify specific markers in tumor tissues, aiding in cancer diagnosis and treatment planning. This test detects the CD1a protein, often found in certain cancers.
IHC ERPR
The IHC ERPR test assesses estrogen and progesterone receptor status in breast cancer tissue, guiding personalized treatment decisions.
Immunohistochemistry CD21 Test
The Immunohistochemistry CD21 Test helps diagnose and classify certain cancers by assessing the CD21 protein in tumor tissue. This information aids oncologists and pathologists in Kenya.
IHC ER-PR HER2NEU
The IHC ER-PR HER2NEU test assesses hormone receptor and HER2 protein status in breast cancer tissue, guiding personalized treatment decisions. Confirm with the laboratory before booking.
Immunohistochemistry ALK1 Test
The Immunohistochemistry ALK1 Test detects ALK gene rearrangements in cancer tissues, aiding in diagnosis and treatment planning, particularly for non-small cell lung cancer.
Immunohistochemistry CD23 Test
The Immunohistochemistry CD23 Test helps identify specific cancer types by detecting CD23 protein expression in tumor tissues, aiding in diagnosis and treatment planning.
IHC Up To 5 Markers
The IHC Up To 5 Markers test uses immunohistochemistry to detect specific proteins in tissue samples, aiding in cancer diagnosis and treatment planning. Requires a doctor's prescription.
Immunohistochemistry CD3 Test
The Immunohistochemistry CD3 Test identifies T-cell populations in tissue samples, aiding in cancer diagnosis and treatment planning.
IHC Extended Panel 10 Markers
The IHC Extended Panel 10 Markers test analyzes tissue samples for 10 specific genetic markers, aiding in cancer diagnosis, treatment planning, and monitoring.
Can Assist Breast Test
The Can Assist Breast Test helps detect specific markers in breast cancer, particularly for patients with ER positive, PR positive, and Her2 negative breast cancer. This test aids in guiding treatment decisions.
Immunohistochemistry CD30 Test
The Immunohistochemistry CD30 Test helps diagnose and manage specific cancers by detecting the CD30 protein in tumor tissue, aiding in treatment planning.
Inv16 AML M4Eo
The Inv16 AML M4Eo test detects a specific genetic abnormality linked to acute myeloid leukemia (AML), aiding in diagnosis and treatment planning.
Immunohistochemistry CD31 Test
The Immunohistochemistry CD31 Test helps identify blood vessel formation in tumors, aiding in cancer diagnosis and treatment planning. It measures CD31 expression in tumor tissue.
Irfa Mum1
The Irfa Mum1 test is a cytogenetic test used in oncology to detect specific genetic abnormalities in tumor tissues, aiding in diagnosis and treatment planning.
Comprehensive Tumor Panel SNVs Small Indels Fusions TMB MSI 526 Genes
A comprehensive genetic test analyzing 526 genes for SNVs, small indels, fusions, TMB, and MSI in tumor tissue. This test helps guide personalized cancer treatment decisions.
Cancer Breast Comprehensive Panel Test
A comprehensive test using advanced techniques to detect and analyze key markers associated with breast cancer, aiding in early diagnosis and treatment planning.
Haloperidol Test
The Haloperidol Test measures haloperidol levels in the blood to help doctors adjust medication dosage for optimal treatment and minimize side effects.
Immunohistochemistry CD35 Test
The Immunohistochemistry CD35 Test helps identify specific proteins in tumor tissue, aiding in the diagnosis and characterization of certain cancers, particularly hematological malignancies. Confirm with the laboratory before booking.
Immunohistochemistry CD5 Test
The Immunohistochemistry CD5 Test helps identify the CD5 protein in tumor tissue, aiding in the diagnosis and management of certain cancers, particularly lymphoid malignancies.
Desgamma Carboxy Prothrombin DCPPIVKA II Serum Test
The Desgamma Carboxy Prothrombin (DCP) test measures levels of a protein that can be elevated in certain cancers, particularly liver cancer. It aids in detection and monitoring.
Immunohistochemistry CD79a Test
The Immunohistochemistry CD79a Test helps identify the CD79a antigen in tumor tissue, aiding in the diagnosis and management of certain cancers, particularly B-cell lymphomas.
Cancer Targeted Gene Panel CNS Tumor Test
A genetic test to identify mutations in central nervous system (CNS) tumors, aiding in personalized cancer treatment planning. Confirm with the laboratory before booking.
Immunohistochemistry CD99 MIC2 Test
The Immunohistochemistry CD99 MIC2 Test helps identify specific cancer types, particularly Ewing's sarcoma and other round cell tumors, aiding in diagnosis and treatment planning.
Immunohistochemistry CEA Carcinoembryonic Antigen Test
The Immunohistochemistry CEA Carcinoembryonic Antigen Test helps detect CEA protein in tumor tissue, aiding in cancer diagnosis and monitoring.
Immunohistochemistry CK56 Test
The Immunohistochemistry CK56 Test helps identify specific protein markers in tumor tissues, aiding in cancer diagnosis and treatment planning.
Pancreatic Polypeptide Test
The Pancreatic Polypeptide Test measures levels of pancreatic polypeptide in the blood to help diagnose pancreatic disorders, including cancer. Confirm with the laboratory before booking.
Immunohistochemistry Cyclind1 Test
The Immunohistochemistry Cyclind1 Test helps identify the Cyclind1 protein in tumor tissue, aiding in cancer diagnosis and treatment planning.
Immunohistochemistry Cytokeratin20 CK20 Test
The Immunohistochemistry Cytokeratin20 (CK20) Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and management.
Immunohistochemistry DOG1 Test
The Immunohistochemistry DOG1 Test helps identify specific proteins in tumor tissue, aiding in the diagnosis and management of certain cancers, particularly gastrointestinal stromal tumors (GISTs).
HCG Beta Total Quantitative Tumor Marker Test
The HCG Beta Total Quantitative Tumor Marker Test measures HCG levels in the blood to help detect and monitor certain cancers, like germ cell tumors. Confirm with the laboratory before booking.
Immunohistochemistry Cytomegalovirus CMV Test
Detects Cytomegalovirus (CMV) in tumor tissue using immunohistochemistry. This test is important for cancer patients, especially those with weakened immune systems, to help guide treatment decisions.
Immunohistochemistry Epidermal Growth Factor Receptor EGFR Test
The Immunohistochemistry Epidermal Growth Factor Receptor (EGFR) Test helps identify specific mutations in tumor tissue, guiding cancer treatment decisions, particularly for non-small cell lung cancer.
Thioridazine Test
Monitor Thioridazine levels in your bloodstream to ensure effective treatment and minimize side effects. Essential for patients on this antipsychotic medication.
Immunohistochemistry Epithelial Membrane Antigen EMA Test
The Immunohistochemistry Epithelial Membrane Antigen (EMA) Test helps identify specific cancer types by analyzing tissue samples for epithelial membrane antigens. This test aids oncologists and pathologists in diagnosis and treatment planning.
Immunohistochemistry Glial Fibrillary Acidic Protein GFAP Test
The Immunohistochemistry Glial Fibrillary Acidic Protein (GFAP) Test helps identify specific proteins in tissue samples, aiding in the diagnosis and classification of brain tumors and certain neurological conditions.
Immunohistochemistry Growth Hormone GH Test
The Immunohistochemistry Growth Hormone (GH) Test helps diagnose hormone-related cancers by measuring GH levels in tumor tissue. This test aids in accurate diagnosis and treatment planning.
Immunohistochemistry Hepatocyte Specific Antigen HSA Test
The Immunohistochemistry Hepatocyte Specific Antigen (HSA) Test helps diagnose liver-related cancers by detecting specific proteins in tumor tissue. This aids doctors in making treatment decisions.
Immunohistochemistry HER2 ERBB2 Breast Test
The Immunohistochemistry HER2 ERBB2 Breast Test helps determine if breast cancer cells overexpress the HER2 protein, guiding treatment decisions.
Thyroglobulin Tg Test
The Thyroglobulin Tg Test measures thyroglobulin levels in the blood to help monitor patients after thyroid cancer treatment.
5 HIAA 5-Hydroxy Indole Acetic Acid Random Urine Test
The 5 HIAA 5-Hydroxy Indole Acetic Acid Random Urine Test helps detect neuroendocrine tumors by measuring serotonin metabolites in urine. It aids in diagnosis and monitoring.
Immunohistochemistry Human Chorionic Gonadotropin HCG Test
The Immunohistochemistry Human Chorionic Gonadotropin (HCG) Test helps detect and diagnose certain cancers, particularly germ cell tumors, by measuring HCG levels in tumor tissue.
Immunohistochemistry HMB45 Test
The Immunohistochemistry HMB45 Test helps identify melanoma and certain other cancers by detecting specific proteins in tissue samples. It is used by doctors to aid in diagnosis and treatment planning.
Liquid Bx Cell Free EGFR T790M L858R Exon 19 Deletion
This non-invasive blood test detects specific EGFR gene mutations (T790M, L858R, Exon 19 deletion) in patients with non-small cell lung cancer, helping guide targeted therapy decisions.
Liquid Bx Cell Free BRAF
A non-invasive blood test to detect BRAF gene mutations in circulating tumor DNA, aiding in cancer diagnosis and treatment planning.
Immunohistochemistry Lambda Light Chains Test
The Immunohistochemistry Lambda Light Chains Test helps diagnose and characterize certain cancers, particularly plasma cell disorders, by analyzing tissue samples. This test provides crucial information for oncologists and pathologists.
Liquid Bx Cell Free KRAS
The Liquid Bx Cell Free KRAS test is a non-invasive blood test used to detect KRAS gene mutations associated with certain cancers. It helps guide personalized cancer treatment.
5HIAA 5-Hydroxy Indole Acetic Acid 24 Hour Urine Test
The 5HIAA 5-Hydroxy Indole Acetic Acid 24 Hour Urine Test measures serotonin metabolism, aiding in the diagnosis and monitoring of neuroendocrine tumors.
Disopyramide Test
Monitor your Disopyramide medication levels with this test. Essential for patients taking Disopyramide for heart conditions to ensure effective treatment and minimize side effects.
Immunohistochemistry Melana Test
The Immunohistochemistry Melana Test uses tissue analysis to help diagnose and classify cancer types, guiding treatment decisions. Confirm with the laboratory before booking.
Liquid Bx Cell Free Pan Ras KRASNRAS
A non-invasive blood test to detect KRAS and NRAS gene mutations, often found in various cancers, aiding in personalized treatment decisions. Confirm with the laboratory before booking.
FISH T 1221 or LSI TELAML1 Test
The FISH T 1221 or LSI TELAML1 Test helps detect specific genetic changes linked to leukemia, aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
Immunohistochemistry Myogenin Test
The Immunohistochemistry Myogenin Test helps identify specific muscle-related tumors by detecting the myogenin protein in tissue samples. This test aids in diagnosing conditions like rhabdomyosarcoma.
Lithium Test
Monitor lithium levels in your blood to ensure effective treatment for bipolar disorder and prevent toxicity. Confirm price before booking.
Lung Cancer Panel 1 EGFR ALK1
Detects specific genetic mutations (EGFR, ALK1) in lung cancer tissue to guide personalized treatment options. Essential for patients diagnosed with lung cancer.
Catecholamines VMA 24 Hour Urine Test
This test measures vanillylmandelic acid (VMA) levels in a 24-hour urine sample. It helps detect catecholamine-secreting tumors, such as neuroblastoma or pheochromocytoma. Confirm with the laboratory before booking.
Immunohistochemistry Neurofilament Polypeptide Test
A specialized test using immunohistochemistry to detect neurofilament proteins in tumor tissue, aiding in cancer diagnosis and classification.
Lung Cancer Panel 2 EGFR ALK1 ROS1
The Lung Cancer Panel 2 (EGFR, ALK1, ROS1) test identifies specific genetic mutations in lung cancer tumor tissue to help guide personalized treatment decisions.
Immunohistochemistry Neuron Specific Enolase NSE Test
The Immunohistochemistry Neuron Specific Enolase (NSE) Test helps detect neuron-specific enolase in tumor tissues, aiding in the diagnosis and management of certain cancers, particularly neuroendocrine tumors.
Lung Cancer Panel 3 EGFR ALK1 ROS1 MET
This genetic test identifies specific mutations (EGFR, ALK1, ROS1, MET) in lung cancer cells, helping guide personalized treatment decisions. Confirm with the laboratory before booking.
Immunohistochemistry p53 Test
The Immunohistochemistry p53 Test helps assess p53 protein expression in tumor tissues, providing valuable information for cancer diagnosis and treatment planning.
Pheochromocytoma Profile Test
The Pheochromocytoma Profile Test helps diagnose pheochromocytoma, a rare tumor causing high blood pressure and other symptoms. It measures key markers in plasma and urine.
Lung Cancer Panel 4 EGFR ALK1 ROS1 MET PD L1
The Lung Cancer Panel 4 test identifies specific genetic mutations (EGFR, ALK1, ROS1, MET, PD L1) in lung cancer tissue. This helps guide personalized treatment decisions.
Cea Carcino Embryonic Antigen Test
The CEA Carcino Embryonic Antigen Test measures levels of a protein in the blood, often used to monitor certain cancers, particularly colorectal cancer, and check for recurrence after treatment.
Doxepin Test
The Doxepin Test measures the amount of Doxepin medication in your blood. This helps your doctor adjust your dosage for effective treatment of depression or anxiety and minimise side effects.
Immunohistochemistry p63 Test
The Immunohistochemistry p63 Test helps identify p63 protein in tumor tissues, aiding in the diagnosis and classification of cancers, especially squamous cell carcinomas.
Lung Cancer Panel 5 EGFR KRAS BRAF ALK1 R OS1
The Lung Cancer Panel 5 test identifies specific genetic mutations (EGFR, KRAS, BRAF, ALK1, R) in lung cancer tissue samples. This information helps doctors choose the most effective treatment options for non-small cell lung cancer.
Immunohistochemistry Prostate Specific Antigen PSA Test
The Immunohistochemistry Prostate Specific Antigen (PSA) Test helps detect and evaluate prostate cancer by measuring PSA levels in prostate tissue samples. Essential for diagnosis and treatment planning.
Lung Cancer Panel 6 EGFR by Sequencing, ALK by IHC, ROS1 by FISH
A comprehensive genetic test for lung cancer, analyzing EGFR, ALK, and ROS1 markers to guide personalized treatment decisions.
Immunohistochemistry Prolactin Test
The Immunohistochemistry Prolactin Test detects prolactin in tumor tissues, aiding in cancer diagnosis and management.
Expert Breast Cancer Panel Test
The Expert Breast Cancer Panel Test is a diagnostic procedure using advanced histopathology techniques to detect breast cancer early. Results help guide treatment decisions.
Lung Cancer Panel 7 EGFR BRAF ALK1 ROS1 MET
A genetic test analysing key mutations (EGFR, BRAF, ALK1, ROS1, MET) in lung cancer tissue to guide personalised treatment.
Immunohistochemistry S100 Test
The Immunohistochemistry S100 Test detects S100 protein markers in tumor tissue, aiding in the diagnosis and management of certain cancers like melanoma.
Expert Panel 2 Test
The Expert Panel 2 Test provides a comprehensive histopathology analysis of tissue samples to aid in cancer diagnosis and treatment planning.
Lung Cancer Panel 8 EGFR BRAF ALK ROS MET PDL1
The Lung Cancer Panel 8 test identifies specific genetic mutations (EGFR, BRAF, ALK, ROS1, MET, PD-L1) in lung cancer tissue. This helps guide personalized treatment decisions for better outcomes. Confirm with the laboratory before booking.
Histopathology Biopsy Large Complex Cancer Specimen Test
A vital test for diagnosing and evaluating large, complex cancer specimens, aiding oncologists in treatment planning. Essential for patients with cancer symptoms or risk factors.
Immunohistochemistry ROS1 IHC Test
The Immunohistochemistry ROS1 IHC Test identifies ROS1 gene rearrangements in tumor tissue, guiding targeted cancer therapy decisions. Available across Kenya.
Expert Panel 3 Test
The Expert Panel 3 Test is a diagnostic tool used in oncology to help detect cancer early. It involves analysing tissue samples (histopathology sections and cytology smears) to identify cancerous cells.
MAF/IgH (MM)
The MAF/IgH (MM) test helps detect genetic abnormalities associated with multiple myeloma, a type of blood cancer. This test aids in diagnosis and treatment planning.
Acid Phosphatase Total Test
The Acid Phosphatase Total Test measures an enzyme level in the blood to help assess prostate health and detect potential disorders.
Expert Panel 4 Test
The Expert Panel 4 Test is a diagnostic tool using histopathology to analyze tissue samples, aiding in cancer detection and treatment planning.
Immunohistochemistry Actin Smooth Muscle Actin Test
The Immunohistochemistry Actin Smooth Muscle Actin Test helps diagnose certain cancers by identifying smooth muscle actin in tumor tissue. This test aids oncologists and pathologists in understanding tumor types.
Immunohistochemistry ACTH Test
The Immunohistochemistry ACTH Test helps detect and diagnose certain cancers by measuring ACTH levels in tumor tissue, aiding oncologists in treatment decisions.
Lung Cancer Mutation Panel Test
The Lung Cancer Mutation Panel Test identifies specific genetic mutations (ALK-1, EGFR) in lung cancer tissue. This information helps doctors choose the most effective, personalized treatment options. Confirm with the laboratory before booking.
Immunohistochemistry AFP Alpha Feto Protein Test
The Immunohistochemistry AFP Alpha Feto Protein Test helps detect and monitor certain cancers by measuring alpha-fetoprotein levels in tumor tissue. Essential for oncologists and pathologists.
Mdm2
The Mdm2 test helps assess genetic markers linked to cancer, aiding in treatment planning. It measures Mdm2 gene expression in tumor tissue using FISH.
Immunohistochemistry Any 3 Markers Without Interpretation Test
Immunohistochemistry (IHC) test identifying three specific protein markers in tumor tissue to aid in cancer diagnosis and treatment planning. This test does not include interpretation.
Immunohistochemistry Any 5 Markers Test
The Immunohistochemistry Any 5 Markers Test analyzes tumor tissue to identify specific cancer markers, aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
MDS Fish Panel (FISH del(5q), del(7q), del(20q))
The MDS Fish Panel (FISH del(5q), del(7q), del(20q)) is a genetic test that detects specific chromosomal abnormalities associated with myelodysplastic syndromes (MDS), aiding in diagnosis and treatment planning.
Immunohistochemistry Any 5 Markers Without Interpretation Test
Immunohistochemistry (IHC) Any 5 Markers test helps identify specific proteins in tissue samples, aiding in cancer diagnosis and treatment planning. This test does not include interpretation.
Immunohistochemistry Digital Breast Cancer Panel 1 Test
The Immunohistochemistry Digital Breast Cancer Panel 1 Test uses advanced techniques to analyze breast tissue, providing crucial information on hormone receptors and malignancy for effective treatment planning.
Acute Lymphoblastic Leukemia All Cytogenetics Panel Test
The Acute Lymphoblastic Leukemia (ALL) Cytogenetics Panel Test identifies chromosomal abnormalities associated with ALL, aiding in diagnosis, treatment planning, and prognosis. Confirm with the laboratory before booking.
Immunohistochemistry CDX2 Test
The Immunohistochemistry CDX2 Test helps identify the CDX2 protein in tumor tissues, aiding in the diagnosis and classification of certain cancers, particularly colorectal cancer.
Chimerism Split Cell Analysis Myeloid Cell CD15 Test
Monitors bone marrow transplant success by measuring donor cell presence in the blood. Essential for post-transplant patient care.
Immunohistochemistry ATRX Test
The Immunohistochemistry ATRX Test assesses ATRX protein expression in tumor tissues, aiding in cancer diagnosis and treatment planning.
Immunohistochemistry Any 3 Markers Test
Immunohistochemistry (IHC) Any 3 Markers Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning. This test is crucial for understanding cancer characteristics and guiding personalized medicine.
Immunohistochemistry BCL2 Test
The Immunohistochemistry BCL2 Test helps diagnose and manage certain cancers, like lymphomas, by detecting the BCL2 protein in tumor tissue. This test provides valuable information for treatment planning.
Immunohistochemistry CD43 Test
The Immunohistochemistry CD43 Test detects the CD43 protein in tumor tissue, aiding in cancer diagnosis and treatment planning.
Lysozyme Muramidase Test
The Lysozyme Muramidase Test measures lysozyme levels in the blood, primarily used to monitor certain cancers and assess treatment response.
Immunohistochemistry CD45 LCA Test
The Immunohistochemistry CD45 LCA Test helps identify specific markers in tumor tissues, aiding in the diagnosis and classification of various cancers, particularly hematological malignancies. Confirm with the laboratory before booking.
Immunohistochemistry Bladder vs Prostate Carcinoma Panel Test
A specialized test using immunohistochemistry to help distinguish between bladder and prostate cancer based on tumor tissue analysis. Essential for accurate diagnosis and treatment planning.
MET Amplification NSCLC
The MET Amplification NSCLC test helps determine if the MET gene is amplified in non-small cell lung cancer (NSCLC) tissue, guiding treatment decisions.
Immunohistochemistry INI1 Test
The Immunohistochemistry INI1 Test helps diagnose certain cancers by checking for the INI1 protein in tumor tissue. This test is important for guiding cancer treatment.
Immunohistochemistry CD19 Test
The Immunohistochemistry CD19 Test helps identify CD19 protein in tumor tissue, aiding in the diagnosis and treatment planning for certain cancers, particularly B-cell malignancies.
Immunohistochemistry Calretinin Test
The Immunohistochemistry Calretinin Test detects calretinin protein expression in tumor tissues, aiding in the diagnosis and classification of certain cancers, particularly mesothelioma. Confirm with the laboratory before booking.
Immunohistochemistry OCt2 Test
The Immunohistochemistry OCt2 Test helps identify and characterize certain types of cancer by analyzing tumor tissue. It aids in diagnosis and treatment planning.
Immunohistochemistry CD20 Test
The Immunohistochemistry CD20 Test detects the CD20 protein in tumor tissue, aiding in the diagnosis and treatment planning for certain B-cell cancers like lymphomas. Confirm with the laboratory before booking.
Immunohistochemistry CD4 Test
The Immunohistochemistry CD4 Test helps identify CD4 markers in tumor tissue, aiding in cancer diagnosis and treatment planning. Available at DNA Labs Kenya.
Immunohistochemistry CD34 Test
The Immunohistochemistry CD34 Test detects the CD34 antigen in tumor tissues, aiding in cancer diagnosis, particularly hematological malignancies, and guiding treatment decisions.
Immunohistochemistry CD45 Ro PAN T Test
The Immunohistochemistry CD45 Ro PAN T Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.
Metanephrines Fractionated Random Urine Test
Detects neuroendocrine tumors like pheochromocytomas by measuring metanephrine and normetanephrine levels in a random urine sample. Essential for early diagnosis and management.
AFP Alpha Fetoprotein Tumor Marker Test
The AFP Alpha Fetoprotein Tumor Marker Test measures levels of alpha-fetoprotein in the blood to help detect certain cancers, like liver cancer and germ cell tumors. It's a key tool for monitoring treatment and assessing risk.
Immunohistochemistry CD56 Test
The Immunohistochemistry CD56 Test detects the CD56 protein in tumor tissue, aiding in cancer diagnosis, classification, and treatment planning.
Immunohistochemistry CD68 Test
The Immunohistochemistry CD68 Test helps identify CD68 markers in tumor tissues, aiding in cancer diagnosis and characterization. This test provides insights into the tumor microenvironment and immune response.
Immunohistochemistry CD8 Test
The Immunohistochemistry CD8 Test helps evaluate the immune response within tumor tissue, aiding in cancer diagnosis and treatment planning.
Immunohistochemistry CDK4 Test
The Immunohistochemistry CDK4 Test helps diagnose and understand certain cancers by measuring CDK4 protein expression in tumor tissue. This aids oncologists in treatment planning.
Immunohistochemistry Chromogranina CGA Test
The Immunohistochemistry Chromogranina CGA Test helps identify neuroendocrine tumors by measuring chromogranin A levels in tissue samples. This test aids oncologists and pathologists in diagnosing and managing certain cancers.
Immunohistochemistry CMyc Test
The Immunohistochemistry CMyc Test helps diagnose and monitor certain cancers by detecting CMyc protein expression in tumor tissue, aiding oncologists in treatment decisions.
Immunohistochemistry Cytokeratin 7 CK7 Test
The Immunohistochemistry Cytokeratin 7 (CK7) Test helps identify specific proteins in tumor tissues, aiding in cancer diagnosis and treatment planning. It is used to determine the origin of tumors.
Chromofic Karyoarray Test
The Chromofic Karyoarray Test uses advanced microarray technology to detect chromosomal abnormalities linked to neurological disorders. It helps in early diagnosis and management.
Immunohistochemistry Cytokeratin Pancytokeratin Test
The Immunohistochemistry Cytokeratin Pancytokeratin Test helps identify and characterize cancerous tissues by detecting cytokeratin proteins, aiding in cancer diagnosis and treatment planning.
Chromogranin A CGA Test
The Chromogranin A (CGA) Test measures levels of CGA in the blood to help detect and monitor neuroendocrine tumors. This test is important for individuals with symptoms or a history related to these types of cancers.
Immunohistochemistry D240 Podoplanin Test
The Immunohistochemistry D240 Podoplanin Test helps identify specific cancer types by detecting the podoplanin marker in tumor tissue. This test aids oncologists in diagnosis and treatment planning.
Chromosome Analysis for Hematologic Malignancy Test
Chromosome Analysis for Hematologic Malignancy Test helps diagnose blood cancers like leukemia and lymphoma by detecting chromosomal abnormalities. Essential for guiding treatment and understanding prognosis.
Hepatocellular Carcinoma HCC Panel Test
The Hepatocellular Carcinoma (HCC) Panel Test assesses liver health and helps detect potential liver cancer. It measures key biomarkers related to liver function and cancer risk.
Immunohistochemistry Cytokeratin 19 CK19 Test
The Immunohistochemistry Cytokeratin 19 (CK19) Test helps identify specific cancer markers in tumor tissues, aiding in the diagnosis and management of certain cancers like lung and breast cancer.
Immunohistochemistry Desmin Test
The Immunohistochemistry Desmin Test helps diagnose muscle-related tumors by detecting desmin protein in tissue samples. It aids oncologists and pathologists in cancer evaluation.
Chromosome Analysis Solid Tumor Test
Chromosome Analysis Solid Tumor Test helps understand the genetic makeup of solid tumors, guiding cancer diagnosis and treatment decisions. Confirm with the laboratory before booking.
1P 19Q Test
The 1P 19Q Test is a genetic analysis used in oncology to identify specific chromosomal deletions (1p and 19q) often found in brain tumors like gliomas. This information helps guide treatment decisions and understand prognosis.
Chromosome Analysis Karyotype Couple Blood Test
Chromosome analysis (karyotype) for couples planning a family or facing reproductive challenges. Identifies chromosomal abnormalities that may affect fertility or offspring health.
Immunohistochemistry Follicle Stimulating Hormone FSH Test
The Immunohistochemistry Follicle Stimulating Hormone (FSH) Test helps detect hormone levels in tissue samples, aiding in cancer diagnosis and treatment planning. This test is used by oncologists and pathologists.
Mll Aml All
The MLL AML ALL test identifies specific genetic changes in leukemia cells, aiding in diagnosis and treatment planning for Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL).
Immunohistochemistry Estrogen Receptor ER Test
The Immunohistochemistry Estrogen Receptor (ER) Test assesses the presence of estrogen receptors in tumor tissue, guiding treatment decisions, particularly for breast cancer. Confirm with the laboratory before booking.
MM Fish Panel FISHdel11q del13q IgH del17p
A specialized genetic test using FISH to detect specific chromosomal deletions (11q, 13q, 17p) and IgH alterations, often used in diagnosing and managing multiple myeloma and related blood cancers.
Immunohistochemistry GATA3 Test
The Immunohistochemistry GATA3 Test helps identify specific tumor types, particularly breast cancer, by detecting the GATA3 protein in tissue samples. This aids in diagnosis and treatment planning.
Immunohistochemistry Galectin3 Test
The Immunohistochemistry Galectin3 Test detects Galectin3 protein in tumor tissue, aiding oncologists in assessing cancer progression and treatment response.
Immunohistochemistry Glycophorin A Test
The Immunohistochemistry Glycophorin A Test helps identify specific cancer types by detecting Glycophorin A in tissue samples. It aids oncologists and pathologists in diagnosis and treatment planning.
All Fish Panel Fish BCR/ABL TEL/AML1 MLL E2A
The All FISH Panel test detects specific genetic abnormalities (BCR/ABL, TEL/AML1, MLL, E2A) associated with certain blood cancers, aiding in diagnosis and treatment planning.
Immunohistochemistry Glutamine Synthetase Test
The Immunohistochemistry Glutamine Synthetase Test helps understand tumor biology and potential treatment responses by measuring glutamine synthetase levels in tumor tissue. Essential for cancer diagnosis and management.
Alk/EmL4 NSCLC
The Alk/EmL4 NSCLC test identifies specific genetic changes in non-small cell lung cancer (NSCLC) to guide targeted treatment decisions.
Immunohistochemistry Glypican3 GPC3 Test
The Immunohistochemistry Glypican3 GPC3 Test detects glypican-3 protein in tumor tissue, aiding in the diagnosis and treatment planning of certain cancers, especially liver cancer.
Immunohistochemistry HHV8 Test
Detects Human Herpesvirus 8 (HHV8) in tumor tissue using immunohistochemistry. This test aids in diagnosing HHV8-associated cancers like Kaposi's sarcoma. Confirm with the laboratory before booking.
Immunohistochemistry Inhibin Test
The Immunohistochemistry Inhibin Test helps detect inhibin levels in tumor tissue, aiding in the diagnosis and management of certain cancers, particularly those related to reproductive organs. Confirm with the laboratory before booking.
Prostate Health Index PHI Test
The Prostate Health Index (PHI) Test is a diagnostic tool used to assess the risk of prostate cancer by measuring specific prostate-related proteins in the blood. It provides a more detailed assessment than PSA alone.
AML FISH Panel (FISH AML/ETO, inv(16), PML/RARA, MLL)
The AML FISH Panel identifies specific genetic abnormalities associated with acute myeloid leukemia (AML) using Fluorescence In Situ Hybridization (FISH). This test helps guide treatment decisions and understand prognosis.
Myeloma Immunoglobulin Heavy Chain (MYEOVIgH MM)
The Myeloma Immunoglobulin Heavy Chain (MYEOVIgH MM) test helps diagnose and monitor multiple myeloma, a type of blood cancer, by detecting abnormal immunoglobulin levels. Confirm with the laboratory before booking.
Immunohistochemistry Kappa Light Chains Test
The Immunohistochemistry Kappa Light Chains Test helps diagnose and monitor certain cancers by detecting specific proteins in tumor tissue samples. This test is used by oncologists and pathologists.
Immunohistochemistry Langerin Test
The Immunohistochemistry Langerin Test helps identify Langerin protein expression in tumor tissue, aiding in cancer diagnosis and treatment planning.
AML Panel Deletion Duplication Detection
The AML Panel Deletion Duplication Detection test identifies genetic changes associated with Acute Myeloid Leukemia (AML) to help guide treatment and understand prognosis.
Fanconi's Anemia Stress Cytogenetics Test
A specialized test to detect genetic abnormalities linked to Fanconi's Anemia, a rare inherited disorder affecting blood cell production. Aids in early diagnosis and management.
Immunohistochemistry Ki67 Test
The Immunohistochemistry Ki67 Test helps assess how quickly cancer cells are dividing in a tissue sample, aiding in understanding tumor aggressiveness and guiding treatment decisions.
AML1ETO AML M2
The AML1ETO AML M2 test detects a specific genetic abnormality associated with acute myeloid leukemia (AML), aiding in diagnosis and treatment planning.
Histocytopathology Slides Blocks Issue Test
A test used by oncologists to analyze tissue samples for accurate diagnosis, aiding in the effective treatment of various diseases.
NMyc Oncogene
The NMyc Oncogene test helps identify genetic changes linked to certain cancers, particularly neuroblastoma. It analyzes tumor tissue to provide insights for diagnosis and treatment planning.
Histo IHCCyto Digitization of Slides Up to 5 Slides Test
Digital analysis of up to 5 histopathology or cytology slides to aid in cancer diagnosis and treatment planning. Results typically available the next day.
Immunohistochemistry LMO2 Test
The Immunohistochemistry LMO2 Test detects LMO2 protein expression in tumor tissues, aiding in cancer diagnosis and treatment planning.
Immunohistochemistry LMWCK Test
The Immunohistochemistry LMWCK Test helps identify specific proteins in cancer tissues, aiding in diagnosis and treatment planning.
Clomipramine Test
The Clomipramine Test measures the level of Clomipramine medication in your blood. This helps your doctor ensure the dose is right for you, maximizing benefits and minimizing side effects.
Felbamate Test
The Felbamate Test measures the level of the anticonvulsant drug Felbamate in your blood. This helps your doctor ensure you are receiving the correct dose for managing epilepsy or seizures.
Immunohistochemistry Luteinizing Hormone LH Test
The Immunohistochemistry Luteinizing Hormone (LH) Test detects LH levels in tumor tissue, aiding in cancer diagnosis and treatment planning.
Immunohistochemistry Lung Non-Small Cell Carcinoma NSCC Panel Test
An essential diagnostic test using immunohistochemistry to identify specific biomarkers in non-small cell lung carcinoma (NSCLC) tumor tissue, aiding in accurate diagnosis and treatment planning.
Metanephrines Fractionated 24 Hour Urine Test
This test measures metanephrines in a 24-hour urine sample to help detect neuroendocrine tumors like pheochromocytomas. It's useful for individuals experiencing symptoms potentially related to excess catecholamines.
Clonazepam Test
The Clonazepam Test measures the amount of clonazepam medication in your blood. This helps your doctor ensure the dose is correct and safe for managing anxiety or seizures.
Immunohistochemistry MDM2 Test
The Immunohistochemistry MDM2 Test detects MDM2 protein in tumor tissue, aiding in cancer diagnosis and treatment planning, particularly for soft tissue sarcomas and certain breast cancers. Confirm with the laboratory before booking.
BCL2IGH T14;18
The BCL2IGH T14;18 test helps identify specific genetic changes linked to certain lymphomas, aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
Immunohistochemistry MUM1 Test
The Immunohistochemistry MUM1 Test helps identify the MUM1 protein in tumor tissue, aiding in cancer diagnosis and treatment planning.
BCL6
The BCL6 test helps identify genetic changes associated with certain cancers, particularly lymphomas, aiding in diagnosis and treatment planning.
Immunohistochemistry Neuroendocrine Tumor Panel Test
The Immunohistochemistry Neuroendocrine Tumor Panel Test helps identify neuroendocrine tumors using specific markers. This test aids in accurate diagnosis and treatment planning.
FISH BCL6 3q27 Gene Rearrangement
The FISH BCL6 3q27 Gene Rearrangement test detects genetic changes in the BCL6 gene, often associated with certain types of cancer, particularly lymphomas. This test helps guide diagnosis and treatment planning.
NTRK1
The NTRK1 test identifies genetic alterations in tumors, aiding in personalized cancer treatment planning. This test detects NTRK1 gene fusions in tumor tissue.
Amitriptyline Test
Therapeutic drug monitoring for Amitriptyline and Nortriptyline. Measures drug levels in serum to optimize dosage and minimize side effects. Essential for patients on these medications.
Vancomycin Test
The Vancomycin Test measures the amount of vancomycin antibiotic in your blood. This helps doctors ensure the dose is effective and safe, especially for serious infections.
BCR-ABL CML AML ALL
The BCR-ABL CML AML ALL test detects a specific genetic abnormality linked to Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL), aiding in diagnosis and treatment planning.
NTRK3
The NTRK3 test identifies genetic alterations in the NTRK3 gene, aiding in personalized cancer treatment planning. Requires a doctor's prescription.
Immunohistochemistry P40 Test
The Immunohistochemistry P40 Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning. Confirm with the laboratory before booking.
Methotrexate Test
The Methotrexate Test measures the level of methotrexate drug in your blood. It helps doctors adjust your dosage for cancer treatment, especially leukemia, to ensure effectiveness and minimize side effects.
NTRK2
The NTRK2 test identifies genetic alterations in tumor tissue, helping guide cancer treatment decisions, particularly for targeted therapies. Confirm with the laboratory before booking.
NTRK1 NTRK2 NTRK3
The NTRK1 NTRK2 NTRK3 test identifies specific genetic mutations in tumor tissue that can guide targeted cancer therapy.
Clozapine Test
Monitors Clozapine and Norclozapine levels in the blood for patients on Clozapine therapy, ensuring effective treatment and minimizing side effects.
Fibroblast Growth Factor FGF2 Test
The Fibroblast Growth Factor FGF2 Test measures levels of FGF2, a protein linked to tumor growth and blood vessel formation. It aids in cancer diagnosis and monitoring.
Immunohistochemistry PAX5 Test
The Immunohistochemistry PAX5 Test helps identify specific markers in tumor tissues, aiding in the diagnosis and classification of certain cancers, particularly those involving B-cells. Confirm with the laboratory before booking.
BCRABL1 Quantification by DD PCR
BCRABL1 Quantification by DD PCR measures the BCR-ABL1 fusion gene in blood, crucial for monitoring chronic myeloid leukemia (CML) treatment response. Confirm with the laboratory before booking.
Immunohistochemistry PAX8 Test
The Immunohistochemistry PAX8 Test helps identify PAX8 protein expression in tumor tissues, aiding in cancer diagnosis and treatment planning.
PSA Prostate-Specific Antigen Free Test
The PSA Prostate-Specific Antigen Free Test helps assess prostate health and detect potential prostate cancer early. This blood test measures the level of free PSA.
Immunohistochemistry PD1 Test
The Immunohistochemistry PD1 Test evaluates PD1 protein expression in tumor tissues, helping determine suitability for immunotherapy in cancer patients.
PSA Profile Test
The PSA Profile Test measures prostate-specific antigen (PSA) levels in the blood to aid in the early detection and monitoring of prostate cancer. Recommended for men over 50 or those with risk factors.
Immunohistochemistry PDL1 SP263 Ventana Test
The Immunohistochemistry PDL1 SP263 Ventana Test detects PD-L1 protein expression in tumor tissue, helping guide cancer treatment decisions, particularly for immunotherapy.
PSA Prostate-Specific Antigen Total Test
The PSA Prostate-Specific Antigen Total Test measures PSA levels in the blood to aid in the early detection and monitoring of prostate health issues, including prostate cancer.
Oncomine Comprehensive Panel, Oncomine Tumor Mutation Burden (TMB), MSI, PDL1
A comprehensive genetic test analyzing tumor tissue and blood to identify mutations, TMB, MSI, and PDL1 expression, aiding in personalized cancer treatment decisions.
Immunohistochemistry PDL1 SP142 Test
The Immunohistochemistry PDL1 SP142 Test assesses PD-L1 protein expression in tumor tissue, helping guide cancer treatment decisions, particularly for immunotherapy.
Oncomine Comprehensive Panel Oncomine Tumor Mutation Burden MSI
An advanced genetic test analysing tumor tissue to guide cancer treatment decisions by measuring Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI).
Immunohistochemistry Perforin Test
The Immunohistochemistry Perforin Test helps evaluate perforin expression in tumor tissues, aiding oncologists in understanding the immune response to cancer and guiding treatment decisions.
Immunohistochemistry Pituitary Adenoma Panel Test
The Immunohistochemistry Pituitary Adenoma Panel Test helps diagnose and characterize pituitary adenomas using advanced techniques to analyze tumor tissue. This test aids in determining appropriate treatment strategies.
FISH T821 or LSI ETOAML1 Test
The FISH T821 or LSI ETOAML1 Test detects specific genetic changes linked to leukemia using Fluorescence In Situ Hybridization (FISH) technology. This test helps in diagnosing and managing certain types of blood cancers.
FISH 11q23 or LSI MLL Gene Breakapart Test
The FISH 11q23 or LSI MLL Gene Breakapart Test helps diagnose and manage leukemia by detecting specific genetic changes in the MLL gene. This test aids doctors in choosing the best treatment plan.
Oncomine Focus Panel PDL1
The Oncomine Focus Panel PDL1 test analyzes tumor tissue to identify genetic mutations and PDL1 protein expression, guiding personalized cancer treatment decisions. Requires a doctor's prescription.
FISH 14q323 or LSI IGH Gene Breakapart Test
The FISH 14q323 or LSI IGH Gene Breakapart Test is a specialized genetic test used to detect specific chromosomal abnormalities associated with leukemia, aiding in diagnosis and treatment planning.
Microarray Gene Chip Scanning Test
The Microarray Gene Chip Scanning Test analyzes genetic material for abnormalities using advanced gene chip technology. It helps identify chromosomal abnormalities and genetic mutations.
FISH 1p 19q Codeletion Test
The FISH 1p 19q Codeletion Test helps identify specific genetic changes on chromosomes 1p and 19q, often found in certain brain tumors like gliomas. This information aids doctors in diagnosis, treatment planning, and understanding prognosis.
Immunohistochemistry Progesterone Receptor PR Test
The Immunohistochemistry Progesterone Receptor (PR) Test assesses hormone receptor status in tumor tissue, primarily used in breast cancer diagnosis and treatment planning.
FISH 17P TP53 Deletion Test
The FISH 17P TP53 Deletion Test uses Fluorescence In Situ Hybridization (FISH) to detect specific genetic abnormalities in chromosome 17, particularly the deletion of the TP53 gene. This test is important for diagnosing and managing Multiple Myeloma.
Immunohistochemistry pS2 Test
The Immunohistochemistry pS2 Test helps assess hormone receptor status in breast cancer, aiding in treatment decisions and prognosis. Confirm with the laboratory before booking.
Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI)
The Oncomine Tumor Mutation Burden (TMB) and Microsatellite Instability (MSI) test analyzes tumor genetics to guide personalized cancer treatment options. It measures mutations in tumor DNA and assesses microsatellite stability.
Immunohistochemistry Prostate Benign vs Malignant Panel Test
This test uses immunohistochemistry to help distinguish between benign (non-cancerous) and malignant (cancerous) prostate tissue, aiding in accurate diagnosis and treatment planning.
Minimal Residual Disease MRD Analysis for B ALL Test
The Minimal Residual Disease (MRD) Analysis for B ALL test detects residual leukemia cells in patients with B-cell Acute Lymphoblastic Leukemia (B ALL), helping oncologists monitor treatment effectiveness and potential relapse.
FISH ALK1 Breakapart Rearrangement Test
The FISH ALK1 Breakapart Rearrangement Test detects genetic changes in the ALK gene, often linked to certain cancers like non-small cell lung cancer. This test helps guide personalized treatment decisions.
Biopsy Breast Modified Radical Mastectomy ER/PR
This test evaluates breast tissue obtained from a modified radical mastectomy biopsy to check for cancer and determine hormone receptor status (ER/PR). This information helps guide treatment decisions.
Immunohistochemistry Sox11 Test
The Immunohistochemistry Sox11 Test helps diagnose certain cancers by detecting the Sox11 protein in tumor tissue, aiding oncologists in treatment planning.
Minimal Residual Disease MRD Monitoring for Multiple Myeloma Test
Monitor your multiple myeloma treatment effectiveness with the Minimal Residual Disease (MRD) Monitoring test. This test detects small numbers of cancer cells remaining after therapy, helping guide further treatment decisions. Confirm with the laboratory before booking.
PDGFR CMML
The PDGFR CMML test helps identify genetic mutations linked to Chronic Myelomonocytic Leukemia (CMML), aiding in diagnosis and treatment planning.
Immunohistochemistry Sox10 Test
The Immunohistochemistry Sox10 Test helps identify specific proteins in tumor tissues, aiding in cancer diagnosis and treatment planning. This test is used to detect the Sox10 protein, often associated with certain types of tumors.
Pdl1 Dako
The PDL1 Dako test measures the expression of the PD-L1 protein in tumor cells, helping determine suitability for certain cancer immunotherapy treatments.
Immunohistochemistry Stat6 Test
The Immunohistochemistry Stat6 Test helps identify specific protein markers associated with certain cancers, aiding in diagnosis and treatment planning.
PDGFR HES
The PDGFR HES test helps identify genetic abnormalities linked to certain cancers, aiding in diagnosis and treatment planning.
FISH BCL6 3q27 Gene Rearrangement Test
The FISH BCL6 3q27 Gene Rearrangement Test identifies genetic changes in the BCL6 gene linked to certain cancers, particularly lymphomas. This test helps guide treatment decisions for oncologists and hematologists.
Pdl1 Sp263 Clone
The PDL1 SP263 Clone test measures the PD-L1 protein in tumor tissue, helping guide immunotherapy treatment decisions for certain cancers. Confirm with the laboratory before booking.
FISH CLL Panel Test
The FISH CLL Panel Test helps diagnose and manage chronic lymphocytic leukemia (CLL) by detecting specific genetic changes in blood or bone marrow cells. This test aids doctors in determining prognosis and guiding treatment decisions.
Immunohistochemistry Synaptophysin Test
The Immunohistochemistry Synaptophysin Test helps identify neuroendocrine tumors by detecting the synaptophysin protein. It is used in cancer diagnosis and treatment planning.
Mitotane Test
The Mitotane Test measures mitotane levels in the blood, helping doctors monitor treatment for adrenal tumors and adjust therapy for better patient outcomes.
FISH BCR ABL or Philadelphia Translocation Test
The FISH BCR ABL or Philadelphia Translocation Test detects the BCR-ABL fusion gene, a key marker for chronic myeloid leukemia (CML) and certain other leukemias. This test aids in diagnosis, treatment planning, and monitoring.
Immunohistochemistry TdT Test
The Immunohistochemistry TdT Test helps identify specific types of cancer, particularly lymphoid malignancies, by detecting the TdT marker in tumor tissue. This aids in diagnosis and treatment planning.
FISH CMYC Amplification Test
The FISH CMYC Amplification Test helps diagnose specific types of lymphoma by detecting genetic changes in the CMYC gene, aiding oncologists in treatment planning.
Immunohistochemistry TFE 3 Test
The Immunohistochemistry TFE 3 Test helps identify specific cancer types by detecting the TFE 3 protein in tumor tissue, aiding oncologists in diagnosis and treatment planning.
FISH Del13q OR LSI D13S319 Test
The FISH Del13q OR LSI D13S319 Test helps detect specific chromosomal changes associated with Multiple Myeloma, aiding in diagnosis and treatment planning.
Immunohistochemistry Thyroglobulin TG Test
The Immunohistochemistry Thyroglobulin TG Test helps in the diagnosis and monitoring of thyroid cancer by detecting thyroglobulin protein in tumor tissue samples.
FISH EGFR Gene Amplification Test
The FISH EGFR Gene Amplification Test detects changes in the EGFR gene, often linked to cancer, especially lung cancer. This test helps doctors choose the best treatment plan for patients.
Immunohistochemistry Thyroid Carcinoma Panel Test
The Immunohistochemistry Thyroid Carcinoma Panel Test helps diagnose and classify thyroid cancer by analysing specific markers in tumor tissue. This test provides crucial information for treatment planning.
FISH Eosinophilic Leukemia Panel Test
The FISH Eosinophilic Leukemia Panel Test uses advanced genetic technology (FISH) to detect specific abnormalities linked to eosinophilic leukemia, aiding in diagnosis and treatment planning.
PMLRARA AML M3 APML
This test detects the PML-RARA fusion gene, a key marker for Acute Promyelocytic Leukemia (APL), a subtype of Acute Myeloid Leukemia (AML). It helps in accurate diagnosis and guides treatment decisions.
FISH Ewing Sarcoma EWS 22q12 EWSR1 Rearrangement Test
This test uses Fluorescence In Situ Hybridization (FISH) to detect specific genetic rearrangements (EWSR1 gene at 22q12) associated with Ewing Sarcoma, a type of cancer often found in children and young adults. Confirm with the laboratory before booking.
Immunohistochemistry TTF1 Thyroid Transcription Factor1 Test
The Immunohistochemistry TTF1 Thyroid Transcription Factor1 Test helps identify thyroid cancer by detecting the TTF1 protein in tissue samples. This test aids in diagnosis and treatment planning.
FISH FGFR1 8p12 Gene Rearrangement Test
Detects genetic rearrangements in the FGFR1 gene on chromosome 8p12, often associated with certain types of leukemia. This test uses FISH technology to identify specific chromosomal changes.
Immunohistochemistry TLE1 1F5 Test
The Immunohistochemistry TLE1 1F5 Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning.
FISH Follicular Lymphoma IGHBCL2 t14;18 Test
The FISH Follicular Lymphoma IGHBCL2 t14;18 Test helps identify a specific genetic change associated with follicular lymphoma, aiding in diagnosis and treatment planning.
Immunohistochemistry Vimentin Test
The Immunohistochemistry Vimentin Test helps identify and classify tumors, particularly those related to mesenchymal tissues. It measures vimentin protein expression in tumor tissue to aid in cancer diagnosis and treatment planning.
VMA Vanillyl Mandelic Acid 24 Hour Urine Test
The VMA Vanillyl Mandelic Acid 24 Hour Urine Test measures catecholamine metabolites in urine to help detect certain neuroendocrine tumors, like pheochromocytomas and neuroblastomas. This test aids in diagnosing conditions related to hormonal activity and potential tumors.
FISH for Her2 Neu
The FISH for Her2 Neu test checks for amplification of the Her2 gene in breast cancer tissue, guiding personalized treatment decisions.
Immunohistochemistry UroplakinIII Test
The Immunohistochemistry UroplakinIII Test helps identify uroplakin III protein in tumor tissues, aiding in the diagnosis and management of certain cancers, particularly those related to the urinary tract.
VMA Vanillyl Mandelic Acid Random Urine Test
The VMA Vanillyl Mandelic Acid Random Urine Test measures levels of vanillylmandelic acid (VMA) in urine to help detect catecholamine-secreting tumors, especially neuroblastoma in children.
FISH Inv16 Or LSI CBFB Test
The FISH Inv16 or LSI CBFB Test uses Fluorescence In Situ Hybridization (FISH) to detect specific genetic changes linked to certain cancers, particularly acute myeloid leukemia (AML).
Immunohistochemistry WT1 Test
The Immunohistochemistry WT1 Test helps identify the WT1 protein, often associated with specific cancers like Wilms' tumor. It aids in diagnosis and management.
FISH MDM2 12q15 Gene Amplification Test
The FISH MDM2 12q15 Gene Amplification Test uses Fluorescence In Situ Hybridization (FISH) to detect amplification of the MDM2 gene on chromosome 12q15, which is associated with certain cancers. This test aids oncologists in diagnosis and treatment planning.
Immunohistochemistry NKX 31 Test
The Immunohistochemistry NKX 31 Test helps identify specific proteins in cancer tissues, aiding in accurate diagnosis and treatment planning.
FISH MDS Panel Chromosomes 5q 7q 8q 20q Test
The FISH MDS Panel Chromosomes 5q 7q 8q 20q Test uses FISH technology to detect specific chromosomal abnormalities linked to myelodysplastic syndromes (MDS) and other blood cancers, aiding in diagnosis and treatment planning.
Immunophenotyping By Flow Cytometry CD117 Test
The Immunophenotyping By Flow Cytometry CD117 Test helps identify specific cell types in blood or bone marrow, aiding in the diagnosis and management of certain cancers, particularly hematological malignancies. Confirm with the laboratory before booking.
Multiple Myeloma Comprehensive Profile Test
A comprehensive blood and bone marrow test used to help diagnose and monitor Multiple Myeloma, a type of blood cancer. This profile provides detailed information about plasma cell activity and related factors.
FISH MET 7q31 Amplification Test
The FISH MET 7q31 Amplification Test detects genetic changes in the MET gene, aiding in cancer diagnosis and treatment planning.
Multiple Myeloma Screening Panel Test
A comprehensive screening test to help detect and monitor multiple myeloma, a type of blood cancer. This panel analyzes serum components to identify abnormalities related to plasma cells.
Roma Risk of Ovarian Malignancy Algorithm Test
The Roma Risk of Ovarian Malignancy Algorithm Test assesses the likelihood of ovarian cancer in women by measuring CA125 and HE4 biomarkers. This test aids in early detection and informed decision-making for women with symptoms or risk factors.
FISH Multiple Myeloma with Positive Selection of CD138 Cells Test
The FISH Multiple Myeloma test identifies specific chromosomal changes in bone marrow cells associated with multiple myeloma, aiding in diagnosis and treatment planning.
Multiple Myeloma Monitoring Panel Test
A comprehensive blood test panel used to monitor patients diagnosed with multiple myeloma, assessing disease progression and response to treatment. Essential for managing this type of blood cancer.
FISH MYCN Amplification Test
The FISH MYCN Amplification Test detects MYCN gene amplifications, often linked to aggressive cancers like neuroblastoma, helping guide treatment decisions.
FISH NSCLC Non-Small Cell Lung Cancer ALK1 ROS1 Test
This test identifies specific genetic changes (ALK and ROS1 rearrangements) in non-small cell lung cancer (NSCLC) tissue samples using FISH technology. Results help guide targeted treatment decisions.
FISH NTRK 1 Gene Rearrangement Assay Test
The FISH NTRK 1 Gene Rearrangement Assay Test detects rearrangements in the NTRK1 gene using FISH technology. This test helps guide personalised cancer treatment strategies.
Immunophenotyping by Flow Cytometry CD MPO Test
The Immunophenotyping by Flow Cytometry CD MPO Test helps identify specific cell types in blood or bone marrow, aiding in the diagnosis and monitoring of certain blood cancers. Confirm with the laboratory before booking.
CCDN1
The CCDN1 test is a genetic test used in oncology to detect chromosomal abnormalities associated with various cancers. It helps understand genetic predispositions and informs treatment decisions.
FISH NTRK 2 Gene Rearrangement Assay Test
The FISH NTRK 2 Gene Rearrangement Assay Test detects genetic changes in the NTRK2 gene, aiding oncologists in personalizing cancer treatment plans. Confirm with the laboratory before booking.
Immunophenotyping by Flow Cytometry CD10 CALLA Test
The Immunophenotyping by Flow Cytometry CD10 CALLA Test helps identify specific cell markers on blood cells, aiding in the diagnosis and classification of certain cancers, particularly hematological malignancies. Confirm with the laboratory before booking.
FISH NTRK 3 Gene Rearrangement Assay Test
This test detects rearrangements in the NTRK3 gene using Fluorescence In Situ Hybridization (FISH). It helps identify specific genetic changes in tumors, guiding personalized cancer treatment decisions.
FISH Opposite Sex BMT XX XY Test
The FISH Opposite Sex BMT XX XY Test uses Fluorescence In Situ Hybridization (FISH) to identify XX and XY chromosomes in donor cells, crucial for assessing compatibility and potential abnormalities before bone marrow transplantation.
CCND1
The CCND1 test is a genetic analysis used in oncology to identify mutations in the CCND1 gene, which can be associated with certain cancers. This information can help guide treatment decisions.
FISH PDGFR Alpha 4q12 Gene Rearrangement Test
The FISH PDGFR Alpha 4q12 Gene Rearrangement Test helps diagnose specific types of leukemia by detecting genetic changes in the PDGFR alpha gene. This information aids doctors in planning effective treatment.
Y Chromosome Microdeletion Detection PCR Test
This genetic test identifies microdeletions on the Y chromosome, a potential cause of male infertility. It helps understand fertility challenges and guide treatment options.
FISH PDGFR Beta 5q33 Gene Rearrangement Test
The FISH PDGFR Beta 5q33 Gene Rearrangement Test detects specific genetic changes linked to certain types of leukemia, aiding in diagnosis and treatment planning.
FISH Postnatal Gender Confirmation Test
The FISH Postnatal Gender Confirmation Test uses Fluorescence In Situ Hybridization to determine a newborn's genetic gender, especially in cases of ambiguous genitalia or suspected gender reversal. This test helps identify potential genetic disorders requiring timely medical attention.
Colon Cancer Comprehensive Panel Genetic Test
Comprehensive genetic test using Next-Generation Sequencing (NGS) to assess inherited mutations linked to an increased risk of colon cancer. Helps identify predispositions for early detection and management.
Replication Factor C1 Mutation Screening RFC1 80GA
The Replication Factor C1 Mutation Screening RFC1 80GA is a genetic test that identifies mutations in the RFC1 gene, which may be associated with an increased risk of certain cancers. This test is important for individuals with a family history of genetic disorders or cancers.
RB1 Gene Deletion and Duplication Detection Retinoblastoma
Detects deletions or duplications in the RB1 gene, crucial for diagnosing Retinoblastoma, a childhood eye cancer. Helps assess risk and guide treatment.
BCL2
The BCL2 test helps identify genetic markers associated with certain cancers, like lymphomas and leukemias, aiding in prognosis and treatment planning. Confirm with the laboratory before booking.
FISH RARA 17q21 Variant Translocation Test
The FISH RARA 17q21 Variant Translocation Test detects specific genetic changes linked to certain cancers, particularly acute promyelocytic leukemia (APL). This test helps guide diagnosis and treatment.
Ret Nslc
The RET NSCLC test identifies mutations in the RET gene associated with non-small cell lung cancer (NSCLC), guiding personalized treatment decisions.
FISH RET Gene 10q112 Rearrangement Test
The FISH RET Gene 10q112 Rearrangement Test detects specific genetic changes in the RET gene, often linked to certain cancers like thyroid cancer. This test helps guide personalized cancer treatment decisions.
Immunophenotyping By Flow Cytometry CD2 Test
The Immunophenotyping By Flow Cytometry CD2 Test helps diagnose and monitor certain blood cancers by analyzing immune cell markers. Confirm with the laboratory before booking.
FISH Sperm Aneuploidy Test
The FISH Sperm Aneuploidy Test uses Fluorescence In Situ Hybridization (FISH) to detect chromosomal abnormalities in sperm, helping to identify potential genetic factors contributing to infertility or recurrent pregnancy loss.
Immunophenotyping by Flow Cytometry CD20 Test
The Immunophenotyping by Flow Cytometry CD20 Test helps diagnose and monitor certain B-cell cancers by detecting the CD20 antigen on B-cells. This test aids doctors in making informed treatment decisions.
FISH ROS1 6q22 Rearrangement Test
The FISH ROS1 6q22 Rearrangement Test detects specific genetic changes in the ROS1 gene, often found in certain cancers like non-small cell lung cancer. This information helps doctors choose the most effective treatment.
Immunophenotyping by Flow Cytometry CD22 Test
The Immunophenotyping by Flow Cytometry CD22 Test helps identify and monitor certain blood cancers like leukemias and lymphomas by analyzing the CD22 protein on blood cells. This test aids healthcare providers in diagnosis and treatment planning.
Myeloproliferative Neoplasia with Eosinophilia Test
This test helps diagnose certain blood cancers by evaluating blood cell production and eosinophil levels. It's important for early detection and guiding treatment.
CLL FISH Panel FISH del(11q) Trisomy 12 del(13q) del(17p)
A specialized genetic test to detect specific chromosomal abnormalities (del(11q), Trisomy 12, del(13q), del(17p)) associated with Chronic Lymphocytic Leukemia (CLL), aiding in prognosis and treatment planning.
FISH Synovial Sarcoma SS18 SYT 18q112 Gene Rearrangement Test
This test detects specific genetic changes (SS18-SYT rearrangement) linked to synovial sarcoma, a rare cancer. It helps confirm diagnosis and guide treatment.
CLL Panel Cytogenetics FISH del(11q) Trisomy 12 del(13q) del(17p)
The CLL Panel Cytogenetics FISH test identifies specific genetic abnormalities in chronic lymphocytic leukemia (CLL) to aid diagnosis and guide treatment.
Eosinophilic Leukemia Panel (FISH PDGFRA, PDGFRB, FGFR1, C BFB)
This test uses FISH technology to detect specific genetic mutations (PDGFRA, PDGFRB, FGFR1) associated with eosinophilic leukemia, aiding in diagnosis and treatment planning.
FISH T 1517 OR LSI PMLRARA Test
The FISH T 1517 OR LSI PMLRARA Test detects specific genetic changes linked to leukemia, aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
Immunophenotyping by Flow Cytometry CD3 Test
The Immunophenotyping by Flow Cytometry CD3 Test helps diagnose and monitor certain cancers by analyzing T-cell populations in blood or bone marrow. Confirm price with the laboratory before booking.
CLL Panel Deletion/Duplication Detection
The CLL Panel Deletion/Duplication Detection test identifies specific genetic changes associated with Chronic Lymphocytic Leukemia (CLL), aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
FISH T1114 or LSI IGHCCNDI Test
The FISH T1114 or LSI IGHCCNDI Test uses advanced genetic technology to detect specific chromosomal changes linked to lymphoma, aiding in diagnosis and treatment planning.
FISH T814 or MYCIGH for Burkitt Non-Hodgkin Lymphoma Test
A specialized test using Fluorescence In Situ Hybridization (FISH) to detect chromosomal abnormalities associated with Burkitt lymphoma, aiding in diagnosis and treatment planning.
CMyc Oncogene
The CMyc Oncogene test helps identify genetic changes linked to various cancers, aiding in understanding tumor behavior and guiding treatment. Available across Kenya.
CMyc All NHL
The CMyc All NHL test helps diagnose and guide treatment for Non-Hodgkin Lymphoma (NHL) by detecting specific genetic abnormalities using FISH technology. Confirm with the laboratory before booking.
Fishmonosomy 7 Del7q31 for AML MDS Test
The Fishmonosomy 7 Del7q31 for AML MDS Test uses FISH technology to detect specific chromosomal abnormalities (Monosomy 7, del7q31) associated with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), aiding in diagnosis and treatment planning.
Immunophenotyping by Flow Cytometry CD38 Test
The Immunophenotyping by Flow Cytometry CD38 Test helps identify specific cell types related to blood cancers like multiple myeloma and leukemia. It measures the CD38 antigen on cells.
ROS 1 NSCLC
The ROS 1 NSCLC test identifies ROS 1 gene rearrangements in non-small cell lung cancer (NSCLC) tumor tissue, guiding targeted therapy decisions.
Fine Needle Aspiration Cytology Prepared 6 Slides
Fine Needle Aspiration Cytology (FNAC) Prepared 6 Slides is a diagnostic test using cells extracted via a thin needle to help detect cancer and other conditions. It is a minimally invasive procedure.
FISHNTRK 12 3 Gene Panel Test
The FISHNTRK 12 3 Gene Panel Test identifies specific genetic alterations in the NTRK gene family associated with various cancers, aiding in personalized treatment planning.
Fine Needle Aspiration Cytology Slide for Review 1218 Slides
Fine Needle Aspiration (FNA) Cytology Slide Review is a diagnostic test using cells collected via a fine needle to examine for abnormalities, often used in cancer detection.
Neuron Specific Enolase NSE Serum Test
The Neuron Specific Enolase (NSE) Serum Test measures levels of an enzyme often elevated in neuroendocrine tumors, aiding in cancer diagnosis and monitoring.
Immunophenotyping By Flow Cytometry CD45 Test
The Immunophenotyping By Flow Cytometry CD45 Test helps identify and classify blood cells, crucial for diagnosing blood cancers like leukemia and lymphoma. This test analyzes the CD45 marker on white blood cells.
Neuroblastoma Profile 24 Hour Urine Test
The Neuroblastoma Profile 24 Hour Urine Test helps detect neuroblastoma, a cancer mainly affecting children, by measuring Vanillyl Mandelic Acid (VMA) and Homovanillic Acid (HVA) levels in a 24-hour urine sample. This test aids in early diagnosis and guides treatment decisions.
Immunophenotyping By Flow Cytometry CD5 Test
The Immunophenotyping By Flow Cytometry CD5 Test helps identify specific cell markers on blood cells, aiding in the diagnosis and management of certain blood cancers like leukemia and lymphoma.
Neuronal Paraneoplastic Autoantibodies Profile Test
This test detects autoantibodies linked to paraneoplastic syndromes, where cancer triggers immune attacks on the nervous system. It helps diagnose neurological symptoms potentially caused by underlying cancer.
CRLF2 CML AML ALL
The CRLF2 CML AML ALL test helps identify genetic markers associated with Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL). This test aids in diagnosis and treatment planning.
Immunophenotyping By Flow Cytometry CD79b Test
The Immunophenotyping By Flow Cytometry CD79b Test helps diagnose certain blood cancers by analyzing specific cell markers. This test aids oncologists in understanding the type of cancer and planning appropriate treatment.
Liquid Biopsy Lung Cancer Test
A non-invasive blood test using Next-Generation Sequencing (NGS) to detect circulating tumor DNA (ctDNA) associated with lung cancer. Offers early detection and monitoring.
Immunophenotyping by Flow Cytometry IgM Heavy Chain Cytoplasmic Test
This test helps identify and classify certain blood cancers, particularly B-cell neoplasms, by analyzing cells in a blood or bone marrow sample using flow cytometry. It looks for IgM heavy chain in the cytoplasm.
Cytology LBC Pap Smear
The Cytology LBC Pap Smear is a screening test to detect abnormal cells in the cervix, aiding in the early detection of cervical cancer or precancerous conditions. Recommended for women aged 21 and above.
Cytology Pap Smear (Two Slides Only)
A vital screening test to detect early signs of cervical cancer by examining cells collected from the cervix. Essential for women's preventive health.
FISH Trisomy 13 Patau Syndrome Test
The FISH Trisomy 13 Patau Syndrome Test uses advanced genetic technology to detect potential chromosomal abnormalities in a fetus during pregnancy. This test helps expectant parents understand the genetic health of their baby.
Immunophenotyping by Flow Cytometry TdT Test
The Immunophenotyping by Flow Cytometry TdT Test helps identify specific cell markers, aiding in the diagnosis and treatment planning of certain blood cancers like leukemia and lymphoma.
FISH for X and Y
The FISH for X and Y test uses Fluorescence In Situ Hybridization to identify abnormalities in the X and Y chromosomes, aiding in the diagnosis of genetic conditions related to sexual development and fertility.
Serotonin 5ht Serum Test
Measures serotonin levels in the blood to help understand mood regulation, digestion, and overall well-being. Useful for individuals experiencing mood disorders or specific health conditions.
FISH Trisomy 18 Edward Syndrome Test
The FISH Trisomy 18 Edward Syndrome Test uses Fluorescence In Situ Hybridization (FISH) to detect an extra copy of chromosome 18 in fetal cells, aiding in the prenatal diagnosis of Edward syndrome.
Solid Tumor Combo1 EGFR ALK ROS1 MET PDL1
A genetic test analyzing key mutations (EGFR, ALK, ROS1, MET, PDL1) in solid tumor tissue to guide personalized cancer treatment.
Immunophenotyping by Flow Cytometry Leukemia Lymphoma Diagnostic Panel Chronic Lymphoproliferative Disorders T B Cell Test
Immunophenotyping by Flow Cytometry helps diagnose Chronic Lymphoproliferative Disorders like leukemia and lymphoma by analyzing blood or bone marrow cells. This test identifies specific cell types to guide treatment.
Del5q MDS
The Del5q MDS test detects a specific genetic abnormality (deletion on chromosome 5) associated with myelodysplastic syndromes (MDS), aiding in diagnosis and treatment planning.
Del20q MDS
The Del20q MDS test detects specific chromosomal abnormalities associated with myelodysplastic syndromes (MDS), aiding in diagnosis and treatment planning.
FISH for Pre or Postnatal Diagnosis Chromosome 18 X Y
The FISH test for Chromosome 18 X Y detects specific chromosomal abnormalities before or after birth. This genetic test provides crucial information for expectant parents.
Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Acute Leukemia T B or Myeloid Test
A specialized test using flow cytometry to identify the specific type of acute leukemia (T, B, or myeloid), crucial for accurate diagnosis and treatment planning.
Del7q MDS
The Del7q MDS test detects chromosomal abnormalities associated with myelodysplastic syndromes (MDS), aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
FISH for Pre or Postnatal Diagnosis Chromosome 13 23
The FISH for Pre or Postnatal Diagnosis Chromosome 13 23 test uses Fluorescence In Situ Hybridization (FISH) to detect chromosomal abnormalities related to Trisomy 13 and 23 during pregnancy.
Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Customized Any 10 Markers Test
Immunophenotyping by Flow Cytometry is a specialized test used to identify and classify leukemia types by analyzing cell surface markers. Essential for accurate diagnosis and treatment planning.
Del11qATM MM CLL
The Del11qATM MM CLL test identifies specific chromosomal deletions associated with Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM), aiding in diagnosis and treatment planning.
FISH for Pre or Postnatal Diagnosis Chromosome 13 22
This test uses Fluorescence In Situ Hybridization (FISH) to detect potential abnormalities in chromosomes 13 and 22 before or after birth. It helps identify conditions like Trisomy 13 and Trisomy 22.
Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel CLLHCLSLL Basic Test
This test uses flow cytometry to identify specific cell markers in blood or bone marrow, aiding in the diagnosis and classification of leukemia, especially Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL).
Del13q MM CLL
The Del13q MM CLL test detects a specific genetic abnormality (deletion on chromosome 13q) associated with Chronic Lymphocytic Leukemia (CLL), aiding in prognosis and treatment planning.
Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel AML Characterization Test
This test uses flow cytometry to analyze blood or bone marrow cells, helping to diagnose and classify leukemia, particularly Acute Myeloid Leukemia (AML). It identifies specific cell markers to guide treatment decisions.
Del17pp53 MM CLL
A genetic test to detect deletions in the 17p chromosome associated with Chronic Lymphocytic Leukemia (CLL), aiding in diagnosis and treatment planning.
Synovial Sarcoma SS18
The Synovial Sarcoma SS18 test helps detect genetic markers associated with Synovial Sarcoma, a rare cancer. This test uses FISH methodology on tumor tissue.
Homovanillic Acid (HVA) 24 Hour Urine Test
The Homovanillic Acid (HVA) 24 Hour Urine Test measures HVA levels in urine collected over 24 hours. This test helps in the detection and monitoring of certain cancers, particularly neuroblastoma. Confirm with the laboratory before booking.
Immunophenotyping by Flow Cytometry Leukemia Monitoring Panel Hairy Cell Test
Monitor hairy cell leukemia with our Immunophenotyping by Flow Cytometry test. This test identifies specific leukemia cells in the blood to track disease progression and treatment response.
Comprehensive Tumor Panel 270 Genes PDL1
A comprehensive genetic test analyzing 270 genes and PDL1 expression in tumor tissue to guide personalized cancer treatment decisions.
Homovanillic Acid HVA Random Urine Test
The Homovanillic Acid (HVA) Random Urine Test measures HVA levels in urine, aiding in the diagnosis and monitoring of neuroblastoma, a type of cancer. Confirm with the laboratory before booking.
Immunophenotyping by Flow Cytometry Lymphoma Diagnostic Panel Test
This test uses flow cytometry to analyze cells from blood, bone marrow, or lymph nodes to help diagnose and classify different types of lymphoma, guiding treatment decisions.
Immunosuppressant Drug Profile 2 Test
Monitor levels of Cyclosporine and Sirolimus with the Immunosuppressant Drug Profile 2 Test. Essential for patients on these medications to ensure effective treatment and minimize side effects.
Immunosuppressant Drug Profile 1 Test
Monitor levels of Tacrolimus and Sirolimus, key immunosuppressant drugs, to ensure effective therapy and minimise toxicity, especially for transplant or autoimmune disease patients.
Telaml All
The Telaml All test helps detect specific genetic markers associated with acute lymphoblastic leukemia (ALL), aiding in diagnosis and treatment planning.
Immunosuppressant Drug Profile 3 Test
Monitor Cyclosporine and Tacrolimus levels with the Immunosuppressant Drug Profile 3 Test. Essential for managing organ transplant and autoimmune disease treatments to ensure effective dosing and minimize side effects. Confirm with the laboratory before booking.
Immunotyping Serum Test
The Immunotyping Serum Test helps diagnose and monitor blood cancers like leukemia and lymphoma by analyzing serum markers. Essential for cancer patients.
Immunosuppressant Drug Profile 4 Test
Monitor Tacrolimus and Everolimus levels with the Immunosuppressant Drug Profile 4 Test. Essential for patients on immunosuppressive therapy to ensure effective treatment and minimize side effects.
E2A All
The E2A All test detects genetic abnormalities related to certain cancers using advanced FISH methodology. Requires a doctor's prescription.
Beta 2 Microglobulin Serum Test
The Beta 2 Microglobulin Serum Test measures levels of beta-2 microglobulin in the blood, aiding in the diagnosis and monitoring of multiple myeloma and related blood disorders.
Hypercalcemia Panel 1 Test
The Hypercalcemia Panel 1 Test helps diagnose conditions related to high calcium levels in the blood and urine. It measures serum calcium, PTH, and 24-hour urine calcium to identify potential bone or cancer disorders.
Immunohistochemistry Microsatellite Instability Panel Test
This test assesses microsatellite instability (MSI) in tumor tissue using immunohistochemistry to help guide cancer treatment decisions.
Beta 2 Microglobulin 24 Hour Urine Test
Measures beta-2 microglobulin levels in a 24-hour urine sample to help assess conditions like multiple myeloma and monitor kidney function.
Hypercalcemia Panel 2 Test
The Hypercalcemia Panel 2 Test evaluates calcium levels and related markers (PTH, Phosphorus, Vitamin D) to help diagnose conditions causing high calcium, such as cancer or bone disorders. Early detection aids timely management.
Immunohistochemistry Napsina Test
The Immunohistochemistry Napsina Test helps identify specific proteins in tumor tissue, aiding in cancer diagnosis and treatment planning. Confirm with the laboratory before booking.
EWSR1 Gene Ewing's Sarcoma
The EWSR1 Gene Ewing's Sarcoma test helps diagnose Ewing's Sarcoma, a rare bone cancer, by identifying specific genetic changes. This test aids in planning effective treatment.
Trisomy 12 CLL
The Trisomy 12 CLL test detects a specific chromosomal abnormality linked to Chronic Lymphocytic Leukemia (CLL), aiding in diagnosis and treatment planning.
Trisomy 8 AML
The Trisomy 8 AML test identifies a specific genetic abnormality (an extra copy of chromosome 8) associated with acute myeloid leukemia (AML), aiding in diagnosis and treatment planning.
Microsatellite Instability MSI IHC Test
The Microsatellite Instability (MSI) IHC Test helps identify cancer risk and guides treatment decisions, particularly for colorectal and endometrial cancers. This test assesses the stability of microsatellites in tumor DNA.
FGFR1
The FGFR1 genetic test analyzes the FGFR1 gene for alterations linked to certain cancers, aiding in diagnosis and personalized treatment planning. Confirm with the laboratory before booking.
Thyroid Prognostication NGS Panel
The Thyroid Prognostication NGS Panel uses advanced genetic sequencing to assess the risk and characteristics of thyroid-related cancers, aiding in personalized treatment planning.
FGFR3/IgH MM
The FGFR3/IgH MM test detects specific genetic abnormalities linked to multiple myeloma, aiding in diagnosis and treatment planning.
Lynch Syndrome Mismatch Repair MMR IHC MLH1 MLH2 MSH6 PMS2
This test checks for protein deficiencies linked to Lynch syndrome, a hereditary condition increasing the risk of certain cancers like colorectal cancer. It helps identify genetic predispositions for early management.
Fish for Pre or Postnatal Diagnosis Chromosome 13 21
This test uses Fluorescence In Situ Hybridization (FISH) to detect potential chromosomal abnormalities, specifically Trisomy 13 and Trisomy 21, in prenatal samples. It helps expectant parents understand the genetic health of their baby.
FGFR1 Solid Tumor
The FGFR1 Solid Tumor Test identifies genetic mutations in the FGFR1 gene associated with solid tumors, aiding in cancer diagnosis and treatment planning.
Fine Needle Aspiration Cytology Effusion Cytology Cell Block
A minimally invasive test using Fine Needle Aspiration Cytology (FNAC) to examine fluid samples (effusions) for cellular abnormalities, aiding in the diagnosis of conditions like cancer.
Mastitis Complete Panel With Lactamase Penicillin Resistance Profile PCR Test
This test helps diagnose mastitis (breast inflammation) and checks if the bacteria causing it are resistant to penicillin antibiotics, guiding effective treatment.
Fine Needle Aspiration Cytology Procedure with Reporting
Fine Needle Aspiration Cytology (FNAC) is a minimally invasive procedure to collect cells from lumps or masses for diagnostic analysis, aiding in the early detection of conditions like cancer.
X Y Sex Mismatch Bone Marrow Transplant
Assesses compatibility for bone marrow transplants by checking for X Y sex mismatch between donor and recipient using FISH technology.
Fine Needle Aspiration Cytology Slide for Review 2430 Slides
A diagnostic test using Fine Needle Aspiration Cytology (FNAC) to examine cellular samples, primarily for cancer detection and evaluation of genetic disorders. Results are typically available within 3 days.
Mastitis Complete Panel Without Lactamase Penicillin Resistance Profile PCR Test
This test helps diagnose mastitis, a breast infection, by identifying bacteria in breast milk or tissue and checking their resistance to certain antibiotics. It is particularly useful for breastfeeding mothers experiencing symptoms like breast pain, swelling, redness, or fever.
Fine Needle Aspiration Cytology Slide for Review 1824 Slides
Fine Needle Aspiration Cytology (FNAC) Slide Review is a diagnostic test used to examine cells from suspicious lumps or masses under a microscope to help detect potential cancer or other abnormalities.
Mastitis Partial Panel Without Lactamase Penicillin Resistance Profile PCR Test
This test helps diagnose mastitis, an inflammation of breast tissue often caused by bacterial infection. It identifies specific bacteria and their resistance to penicillin, guiding effective treatment.
Fine Needle Aspiration Cytology Slide for Review 612 Slides
Fine Needle Aspiration Cytology (FNAC) Slide Review: A diagnostic test using cellular samples to help detect cancer and other genetic conditions. Essential for early diagnosis and treatment planning.
Mastitis Partial Panel With Lactamase Penicillin Resistance Profile PCR Test
A PCR test to help diagnose mastitis in breastfeeding women and identify penicillin resistance, guiding effective treatment.
Fine Needle Aspiration Cytology Slide for Review 3035 Slides
Fine Needle Aspiration Cytology (FNAC) Slide Review is a diagnostic test used in oncology to evaluate cellular samples for abnormalities, aiding in cancer detection and treatment planning.
Fluid Cytology Urine/Csf/Cytology
Fluid Cytology Urine/Csf/Cytology test examines cells in urine or cerebrospinal fluid (CSF) to detect abnormalities, aiding in the diagnosis of conditions like cancer. Confirm with the laboratory before booking.
FOXO1 Break Apart FISH Alveolar Rhabdomyosarcoma Diagnostic
A specialized genetic test using FISH to detect FOXO1 gene rearrangements in tumor tissue, aiding in the diagnosis and treatment planning for Alveolar Rhabdomyosarcoma.
Germ Cell Tumor Panel Test
The Germ Cell Tumor Panel Test helps detect germ cell tumors by measuring key tumor markers like AFP, HCG, and LDH. This test aids in the diagnosis and management of these cancers.
Immunofixation Electrophoresis IFE 24 Hour Urine Test
Detects monoclonal proteins in a 24-hour urine sample, often associated with certain cancers like multiple myeloma. Aids in diagnosis and monitoring.
Glioma Panel (MGMT, IDH1&2, FISH 1p19q)
The Glioma Panel (MGMT, IDH1&2, FISH 1p19q) is a genetic test used to analyze specific markers in brain tumors (gliomas) to help guide treatment decisions.
Immunohistochemistry Betacatenin Test
The Immunohistochemistry Betacatenin Test helps identify specific cancer markers in tissue samples, aiding in diagnosis and treatment planning. Confirm with the laboratory before booking.
Immunohistochemistry CD163 Test
The Immunohistochemistry CD163 Test helps identify macrophage activity in tumor tissues, aiding in cancer diagnosis and treatment planning.